Personalized and Genomic Cancer Therapy
Cancer, once a monolithic adversary, now unveils its secrets to the discerning gaze of personalized medicine. Personalized and Genomic Cancer Therapy emerges as a vanguard journal, illuminating the intricate pathways of genomic variation and charting the course towards individualized, transformative treatments. Here, we celebrate the dawn of a new era in cancer care, where genetic blueprints guide therapeutic decisions, empower patients, and rewrite the narrative of this once-feared disease.
Access policy: Open access
Review policy: Double-blind peer review
Frequency: Publish continuously
Join Our Esteemed Editorial Board!
We are excited to announce that Personalized and Genomic Cancer Therapy is now welcoming applications for new Editorial Board Members. This is a unique opportunity for experienced scholars and professionals to contribute to the advancement of research and be part of an international academic community.
Who We Are Looking For:
- Experts with a strong publication record in Genomic Cancer.
- Researchers passionate about ensuring high-quality, peer-reviewed content.
- Professionals with experience in journal editing, peer-reviewing, or academic publishing.
Responsibilities:
- Review and provide feedback on submitted manuscripts.
- Assist in shaping the journal’s editorial policies and scope.
- Support special issue planning and new initiatives.
Benefits of Joining:
- Collaborate with a network of renowned scholars.
- Enhance your academic profile and visibility.
- Gain recognition for your contributions in editorial work.
How to Apply:
To express your interest, please email the following documents to [email protected] by 31, October 2024.
- Updated CV
- Brief cover letter (explaining your expertise and motivation)
- List of publications or areas of interest
We look forward to welcoming you to the Personalized and Genomic Cancer Therapy team and working together to advance knowledge in the field!
For any inquiries, feel free to contact us at [email protected]